Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Trimetazidine was identified without a priori hypothesis using a gene-expression signature for the effects of a combination of drugs used to treat bipolar disorder and screening a library of off-patent drugs in cultured human neuronal-like cells
Legal Implications BPC-157 is currently not an approved drug, but a research chemical
Results Study population Participants ( N = 100) were assigned to JNJ-42165279 (FAAHi, n = 51) or placebo (PBO, n = 49
Leng et al., 2019
This protective effect was further validated during parthenogenetic activation, where aged oocytes displayed a fragmentation rate reduction of approximately 27% following Epitalon treatment
US$ 22.93
US$ 25.23
US$ 29.58
